Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
暂无分享,去创建一个
R. James | W. Chan | Richard James | C. Penfold | Neil R Thomas | Weng C Chan | N. R. Thomas | Rachel Warfield | Philip Bardelang | Helen Saunders | Christopher Penfold | R. Warfield | P. Bardelang | H. Saunders
[1] D. Ullmann,et al. Design and synthesis of fluorogenic trypsin peptide substrates based on resonance energy transfer. , 1998, Analytical biochemistry.
[2] L. Heath,et al. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus , 1995, Applied and environmental microbiology.
[3] R. Knox,et al. “Celbenin” - resistant Staphylococci , 1961 .
[4] R. Zhou,et al. A dye release assay for determination of lysostaphin activity. , 1988, Analytical biochemistry.
[5] I. Márová,et al. Modified simplified method for isolation of lysostaphin from the culture filtrate ofStaphylococcus staphylolyticus , 2008, Folia Microbiologica.
[6] S. Walsh,et al. Lysostaphin-Coated Catheters Eradicate Staphylococccus aureus Challenge and Block Surface Colonization , 2004, Antimicrobial Agents and Chemotherapy.
[7] J. Robinson,et al. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus , 1979, Journal of bacteriology.
[8] S. A. Kline,et al. A colorimetric microtiter plate assay for lysostaphin using a hexaglycine substrate. , 1994, Analytical biochemistry.
[9] E. Katchalski‐Katzir,et al. Intramolecularly quenched fluorogenic substrates for hydrolytic enzymes. , 1979, Analytical biochemistry.
[10] S. V. Sinitsyn,et al. H2O2-Induced Inhibition of Photosynthetic O2 Evolution by Anabaena variabilis Cells , 2004, Biochemistry (Moscow).
[11] L. S. Harrow. Organic Syntheses, Collective , 1955 .
[12] M. Sugai,et al. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1 , 1997, Journal of bacteriology.
[13] L. Juliano,et al. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme. , 1999, Journal of hypertension.
[14] L. Juliano,et al. Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides. , 2001, Analytical biochemistry.
[15] S. G. Odintsov,et al. Latent LytM at 1.3A resolution. , 2004, Journal of molecular biology.
[16] M. Bochtler,et al. Crystal structures of active LytM. , 2005, Journal of molecular biology.
[17] N. Thornberry,et al. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer. , 1994, Peptide research.
[18] S. Walsh,et al. Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model , 2003, Antimicrobial Agents and Chemotherapy.
[19] Mary Jane Ferraro,et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus , 2001, The Lancet.
[20] B. Dunn,et al. Peptide Synthesis Protocols , 1994 .
[21] Gary T. Wang,et al. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. , 1990, Science.
[22] R. Jayaswal,et al. Molecular cloning, sequencing, and expression of lytM, a unique autolytic gene of Staphylococcus aureus , 1997, Journal of bacteriology.
[23] D. Ohman,et al. A continuous spectrophotometric assay for Pseudomonas aeruginosa LasA protease (staphylolysin) using a two-stage enzymatic reaction. , 2004, Analytical biochemistry.
[24] Th. Förster. Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .
[25] O. Schneewind,et al. Cross-Linked Peptidoglycan Mediates Lysostaphin Binding to the Cell Wall Envelope of Staphylococcus aureus , 2006, Journal of bacteriology.
[26] V. Surovtsev,et al. Michaelis-Menten Kinetics for Determining Enzymatic Activity of Lysostaphin , 2004, Biochemistry (Moscow).
[27] I. Márová,et al. Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions , 2008, Folia Microbiologica.
[28] M. Jevons,et al. Cellbenin-resistant staphylococci. , 1961 .
[29] C. Tellier,et al. Synthesis of 15 Enriched Phospholipids by Transphosphatidylation , 1985 .
[30] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[31] D. Boger,et al. Key analogs of the tetrapeptide subunit of RA-VII and deoxybouvardin. , 1995, Bioorganic & medicinal chemistry.
[32] F. Tenover,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.
[33] W. Schröder,et al. Site-Specific Serine Incorporation by Lif and Epr into Positions 3 and 5 of the Staphylococcal Peptidoglycan Interpeptide Bridge , 2000, Journal of bacteriology.
[34] C. Schindler,et al. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[35] F. Götz,et al. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus , 1997, Molecular microbiology.
[36] M. Sugai,et al. Cell Wall-targeting Domain of Glycylglycine Endopeptidase Distinguishes among Peptidoglycan Cross-bridges* , 2006, Journal of Biological Chemistry.